Abbonarsi

Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus - 21/04/12

Doi : 10.1016/j.gie.2012.01.029 
M. Kareem Shariff, MBBS, MRCP , 1, Elizabeth L. Bird-Lieberman, MB BChir, MRCP, PhD , 1, Maria O'Donovan, MB, MD, PRCPath 2, Zarah Abdullahi, BSc 1, Xinxue Liu, MD, PhD 1, Jane Blazeby, BSc, MB BChir, MD, FRCS, MSc 3, Rebecca Fitzgerald, MD 1,
1 MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, United Kingdom 
2 Department of Histopathology, Addenbrookes Hospital, Cambridge, United Kingdom 
3 Research Associate MRC Cancer Cell Unit, School of Social & Community Medicine, University of Bristol, United Kingdom 

Reprint requests: Rebecca C. Fitzgerald, MD, MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Hills Road, Cambridge, United Kingdom CB22 7QD

Riassunto

Background

Unsedated transnasal endoscopy (TNE) may be safer and less expensive than standard endoscopy (SE) for detecting Barrett's esophagus (BE). Emerging technologies require robust evaluation before routine use.

Objective

To evaluate the sensitivity, specificity, and acceptability of TNE in diagnosing BE compared with those of SE.

Design

Prospective, randomized, crossover study.

Setting

Single, tertiary-care referral center.

Patients

This study enrolled consecutive patients with BE or those referred for diagnostic assessment.

Intervention

All patients underwent TNE followed by SE or the reverse. Spielberger State-Trait Anxiety Inventory short-form questionnaires, a visual analogue scale, and a single question addressing preference for endoscopy type were administered.

Main Outcome Measurements

Diagnostic accuracy and tolerability of TNE were compared with those of SE.

Results

Of 95 patients randomized, 82 completed the study. We correctly diagnosed 48 of 49 BE cases by TNE for endoscopic findings of columnar lined esophagus compared with the criterion standard, SE, giving a sensitivity and specificity of 0.98 and 1.00, respectively. The BE median length was 3 cm (interquartile range [IQR] 1-5 cm) with SE and 3 cm (IQR 2-4 cm) with TNE, giving high correlations between the two modalities (R2 = 0.97; P < .001). The sensitivity and specificity for detecting intestinal metaplasia by TNE compared with those by SE was 0.91 and 1.00, respectively. The mean (± standard deviation) post-endoscopy Spielberger State-Trait Anxiety Inventory short-form score for TNE (30.0 ± 1.10 standard error of the mean [SEM]) was lower than that for SE (30.7 ± 1.29 SEM), (P = .054). The visual analogue scale scores were no different (P = .07). The majority of patients (59%) expressed a preference for TNE.

Limitations

This is a small study, with limited generalizability, a high prevalence of patients with BE, differential drop-out between the two procedures, and use of sedation.

Conclusion

TNE is an accurate and well-tolerated method for diagnosing BE compared with SE. TNE warrants further evaluation as a screening tool for BE.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : BE, CI, IM, SE, STAI, TNE


Mappa


 DISCLOSURE: This study was supported by funding from the McCord Foundation (to R.F.), Cambridge Experimental Cancer Medicine Centre, NIHR Cambridge Biomedical Research Centre, and a core grant from the Medical Research Council. All funding was awarded to R.F. No other financial relationships relevant to this publication were disclosed.
 If you would like to chat with an author of this article, you may contact Dr Fitzgerald at rcf@hutchison-mrc.cam.ac.uk.


© 2012  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 75 - N° 5

P. 954-961 - maggio 2012 Ritorno al numero
Articolo precedente Articolo precedente
  • Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video)
  • Anne F. Peery, Toshitaka Hoppo, Katherine S. Garman, Evan S. Dellon, Norma Daugherty, Susan Bream, Alejandro F. Sanz, Jon Davison, Melissa Spacek, Diane Connors, Ashley L. Faulx, Amitabh Chak, James D. Luketich, Nicholas J. Shaheen, Blair A. Jobe, Barrett's Esophagus Risk Consortium
| Articolo seguente Articolo seguente
  • Ultrathin transnasal endoscopy without sedation: the straight skinny
  • Douglas G. Adler

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.